Home Depot Executives Break Down a "Noisy" Quarter
The retailer explained to investors why sales growth came up short again.
Editors' Picks
Weibo's Q1 Was All Right, but Ad Sales Are Slowing Down in Q2
The so-called Twitter of China posted solid first-quarter results, but management expects slower sales growth in the next quarter.
Ask a Fool: Are All Dividends Taxed at Lower Rates Than Ordinary Income?
Most -- but not all -- dividends get favorable tax treatment.
One Industry Amazon Is Set to Disrupt
Food service distribution may be in for a wake-up call if Amazon continues to expand in the space.
Recent articles
New Bill Could Mean Changes to IRA Rules
Here’s what it means for your Individual Retirement Account and other retirement planning options.
Is Skyworks Solutions a Buy?
The trade war clouds Skyworks Solutions' near-term outlook, but its 5G-driven future should still be bright.
Is Transocean a Buy?
Based on the book value of its assets, yes. But that's only if the company can turn those assets into greater cash flow going forward.
3 Dividend Stocks That Pay You More Than Pepsi Does
The beverage and snack giant has a great dividend profile, but these three companies sport bigger yields.
Redfin’s Crazy Strong Advantage Over Traditional Real Estate
Real estate is ripe for disruption, and Redfin is entirely capable of disrupting it (and pocketing the difference).
What Kohl's and J.C. Penney Executives Are Saying About Weak Q1 Earnings
The management teams at both midprice department store companies are confident about their plans, but there aren't many clear signs of progress.
3 Key Things From NVIDIA's Q1 Earnings Call That Investors Should Know
Gaming laptops and AI inferencing were bright spots in the GPU specialist's poor quarter.
Can California's Low-Carbon Fuel Standard Boost This Renewable Energy Stock?
The state's ambitious and stable fuel policy provides a much-needed safe haven from uncertainty in the nation's capital. But there's a catch.
Will Xilinx Survive the U.S.-China Trade War?
One of the hottest chip stocks out there is taking a breather.
Approval of a Game-Changing Gene Therapy for SMA Delivers a Win for Novartis and Regenxbio
A $2.1 million price tag could make Zolgensma a blockbuster medicine for these companies.
3 Dividend Stocks Ideal for Retirees
These three stocks could be a great place to put your nest egg to work.
Here's Why Dynavax Technologies Is Tumbling
The company's latest restructuring announcement isn't sitting well with investors.
Foot Locker Affirms Its Growth Outlook As Expenses Jump
The retailer is on track for another record revenue year in 2019.
The 3 Biggest Unknowns That Could Wreck Your Retirement
Plan for them today so they don't devastate your savings in the future.
Intuit Raises Full-Year Guidance After a Strong Tax Season
The software giant's tax and small-business ecosystem segments both notched vigorous growth over the last three months.
Why Investors Are More Bearish About Best Buy, More Bullish About L Brands
The electronics chain could get wounded by the trade war -- but politics or no politics, people are still buying lotions and candles.
Why Shares of Splunk Fell on Friday
Analysts looked past stronger-than-expected earnings and focused instead on cash flow projections.
Home Depot Executives Break Down a "Noisy" Quarter
The retailer explained to investors why sales growth came up short again.
What Happened in the Stock Market Today
Splunk fell despite beating expectations, while Intuit rose after a strong tax season and an improved forecast for the year.
Why Is No One Talking About Repligen Stock?
The business enables the safe and cost-efficient production of biopharmaceuticals -- and that's been a remarkably lucrative niche.